These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15161547)

  • 1. Transcriptional repression of hDaxx enhanced by adenovirus 12 E1B 55-kDa oncoprotein interacting with hDaxx.
    Wan YP; Wu YM; Zhu CM; Yin WG; Cai HL; Yu MJ
    Chin Med J (Engl); 2004 May; 117(5):753-7. PubMed ID: 15161547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
    Kim EJ; Park JS; Um SJ
    Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus E1B 55-kilodalton oncoprotein binds to Daxx and eliminates enhancement of p53-dependent transcription by Daxx.
    Zhao LY; Colosimo AL; Liu Y; Wan Y; Liao D
    J Virol; 2003 Nov; 77(21):11809-21. PubMed ID: 14557665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs).
    Torii S; Egan DA; Evans RA; Reed JC
    EMBO J; 1999 Nov; 18(21):6037-49. PubMed ID: 10545115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML.
    Li H; Leo C; Zhu J; Wu X; O'Neil J; Park EJ; Chen JD
    Mol Cell Biol; 2000 Mar; 20(5):1784-96. PubMed ID: 10669754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.
    Xu Y; Ahn JH; Cheng M; apRhys CM; Chiou CJ; Zong J; Matunis MJ; Hayward GS
    J Virol; 2001 Nov; 75(22):10683-95. PubMed ID: 11602710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential.
    Lin DY; Lai MZ; Ann DK; Shih HM
    J Biol Chem; 2003 May; 278(18):15958-65. PubMed ID: 12595526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
    Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
    Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homeodomain-interacting protein kinase 1 modulates Daxx localization, phosphorylation, and transcriptional activity.
    Ecsedy JA; Michaelson JS; Leder P
    Mol Cell Biol; 2003 Feb; 23(3):950-60. PubMed ID: 12529400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek.
    Hollenbach AD; McPherson CJ; Mientjes EJ; Iyengar R; Grosveld G
    J Cell Sci; 2002 Aug; 115(Pt 16):3319-30. PubMed ID: 12140263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.
    Lehembre F; Müller S; Pandolfi PP; Dejean A
    Oncogene; 2001 Jan; 20(1):1-9. PubMed ID: 11244500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx.
    Hollenbach AD; Sublett JE; McPherson CJ; Grosveld G
    EMBO J; 1999 Jul; 18(13):3702-11. PubMed ID: 10393185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection.
    Tavalai N; Papior P; Rechter S; Stamminger T
    J Virol; 2008 Jan; 82(1):126-37. PubMed ID: 17942542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx.
    Hofmann H; Sindre H; Stamminger T
    J Virol; 2002 Jun; 76(11):5769-83. PubMed ID: 11992005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of the 58-kDa microspherule protein in the modulation of Daxx-dependent transcriptional repression as revealed by nucleolar sequestration.
    Lin DY; Shih HM
    J Biol Chem; 2002 Jul; 277(28):25446-56. PubMed ID: 11948183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PML nuclear bodies and apoptosis.
    Takahashi Y; Lallemand-Breitenbach V; Zhu J; de Thé H
    Oncogene; 2004 Apr; 23(16):2819-24. PubMed ID: 15077145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcriptional repressor hDaxx potentiates p53-dependent apoptosis.
    Gostissa M; Morelli M; Mantovani F; Guida E; Piazza S; Collavin L; Brancolini C; Schneider C; Del Sal G
    J Biol Chem; 2004 Nov; 279(46):48013-23. PubMed ID: 15339933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DAXX silencing suppresses mouse ovarian surface epithelial cell growth by inducing senescence and DNA damage.
    Pan WW; Yi FP; Cao LX; Liu XM; Shen ZF; Bu YQ; Xu Y; Fan HY; Song FZ
    Gene; 2013 Sep; 526(2):287-94. PubMed ID: 23542781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumoylation of Daxx regulates IFN-induced growth suppression of B lymphocytes and the hormone receptor-mediated transactivation.
    Muromoto R; Ishida M; Sugiyama K; Sekine Y; Oritani K; Shimoda K; Matsuda T
    J Immunol; 2006 Jul; 177(2):1160-70. PubMed ID: 16818774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daxx-beta and Daxx-gamma, two novel splice variants of the transcriptional co-repressor Daxx.
    Wethkamp N; Hanenberg H; Funke S; Suschek CV; Wetzel W; Heikaus S; Grinstein E; Ramp U; Engers R; Gabbert HE; Mahotka C
    J Biol Chem; 2011 Jun; 286(22):19576-88. PubMed ID: 21482821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.